Virtus Biotech Clinical Trials ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 42.98
成立日期: 16/12/2014
 
分析
市值分佈:
21.79%
大市值
42.44%
中市值
31.91%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 19/09/2026 05:40) 總持有投資項目: 95  
0%
 
100%
     10大 (12.18%)
代號 名稱 佔比% ▼ 持有日期
GHRSGH Research PLC0.8931/07/2026
PVLAPalvella Therapeutics Inc0.8731/08/2026
KYMRKymera Therapeutics0.8631/08/2026
SLSSELLAS Life Sciences Group0.8631/07/2026
REPLReplimune Group0.8431/07/2026
ANROAlto Neuroscience0.8431/07/2026
ANLAdlai Nortye Group Ltd.0.8431/07/2026
RVMDRevolution Medicines0.8331/08/2026
IMNMImmunome0.8331/07/2026
MGTXMeiraGTx Holdings plc0.8231/07/2026
SGPSpyGlass Pharma Inc0.8231/07/2026
KODKodiak Sciences0.8231/07/2026
CGEMCullinan Therapeutics0.8131/07/2026
LXRXLexicon Pharmaceuticals0.8131/07/2026
BHVNBiohaven Ltd0.8031/07/2026
NKTRNektar Therapeutics0.8031/07/2026
ALMSAlumis Inc.0.7831/07/2026
CADLCandel Therapeutics0.7831/07/2026
SANASana Biotechnology0.7831/07/2026
ELVNEnliven Therapeutics0.7831/08/2026
  1   2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.